These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 3239954
1. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine. Kobayashi T, Goto I, Yamanaka T, Suzuki Y, Nakano T, Suzuki K. Ann Neurol; 1988 Oct; 24(4):517-22. PubMed ID: 3239954 [Abstract] [Full Text] [Related]
2. Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach. Esch SW, Williams TD, Biswas S, Chakrabarty A, LeVine SM. Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):779-87. PubMed ID: 14528915 [Abstract] [Full Text] [Related]
3. Galactosylceramide and galactosylsphingosine loading studies in cultured skin fibroblasts in human and murine globoid cell leukodystrophy. Ida H, Kusano K, Suzuki H, Tokoro T, Eto Y. Biochem Biophys Res Commun; 1990 Jan 30; 166(2):1053-60. PubMed ID: 2302222 [Abstract] [Full Text] [Related]
4. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease. Kobayashi T, Shinoda H, Goto I, Yamanaka T, Suzuki Y. Biochem Biophys Res Commun; 1987 Apr 14; 144(1):41-6. PubMed ID: 3579916 [Abstract] [Full Text] [Related]
6. Accumulation of galactosylsphingosine (psychosine) in the twitcher mouse: determination by HPLC. Shinoda H, Kobayashi T, Katayama M, Goto I, Nagara H. J Neurochem; 1987 Jul 14; 49(1):92-9. PubMed ID: 3585345 [Abstract] [Full Text] [Related]
13. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy. Matthes F, Andersson C, Stein A, Eistrup C, Fogh J, Gieselmann V, Wenger DA, Matzner U. Exp Neurol; 2015 Sep 14; 271():36-45. PubMed ID: 25956830 [Abstract] [Full Text] [Related]
14. Metabolism of galactosylceramide in the twitcher mouse, an animal model of human globoid cell leukodystrophy. Kobayashi T, Shinnoh N, Kuroiwa Y. Biochim Biophys Acta; 1986 Nov 14; 879(2):215-20. PubMed ID: 3094585 [Abstract] [Full Text] [Related]
15. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease. Ribbens JJ, Moser AB, Hubbard WC, Bongarzone ER, Maegawa GH. Mol Genet Metab; 2014 Feb 14; 111(2):172-83. PubMed ID: 24094551 [Abstract] [Full Text] [Related]
16. Detection of Krabbe disease using tritiated galactosylceramides with medium-chain fatty acids. Parvathy MR, Ben-Yoseph Y, Mitchell DA, Nadler HL. J Lab Clin Med; 1987 Dec 14; 110(6):740-6. PubMed ID: 3681116 [Abstract] [Full Text] [Related]
17. The twitcher mouse: accumulation of galactosylsphingosine and pathology of the central nervous system. Tanaka K, Nagara H, Kobayashi T, Goto I. Brain Res; 1989 Mar 20; 482(2):347-50. PubMed ID: 2706492 [Abstract] [Full Text] [Related]